ArticleClinical epigenetics2021

CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients.

Karolin Heinze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.